Sichuan Baili Pharmaceutical Co.

SEP 10, 2026 · PHASE 3 TRIAL

A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)

ClinicalTrials.gov

This is a clinical trial registry record describing a planned Phase 3 study with no results reported; the trial is actively recruiting and outcome data are not yet available.

AUG 17, 2026 · PHASE 1 TRIAL

A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid Tumors

ClinicalTrials.gov

This is a Phase 1 trial registration with no results reported; it describes a planned dose-escalation and safety study in an early stage of drug development.

AUG 7, 2026 · PHASE 1 TRIAL

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

ClinicalTrials.gov

Phase 1 dose-escalation trial of a novel bispecific antibody in solid tumors; designed to establish safety and tolerability with preliminary efficacy assessment, not yet recruiting and results not reported.